BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 12671696)

  • 1. Oral mucositis and selective elimination of oral flora in head and neck cancer patients receiving radiotherapy: a double-blind randomised clinical trial.
    Stokman MA; Spijkervet FK; Burlage FR; Dijkstra PU; Manson WL; de Vries EG; Roodenburg JL
    Br J Cancer; 2003 Apr; 88(7):1012-6. PubMed ID: 12671696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucositis reduction by selective elimination of oral flora in irradiated cancers of the head and neck: a placebo-controlled double-blind randomized study.
    Wijers OB; Levendag PC; Harms ER; Gan-Teng AM; Schmitz PI; Hendriks WD; Wilims EB; van der Est H; Visch LL
    Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):343-52. PubMed ID: 11380220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucositis prevention by selective elimination of oral flora in irradiated head and neck cancer patients.
    Spijkervet FK; van Saene HK; van Saene JJ; Panders AK; Vermey A; Mehta DM
    J Oral Pathol Med; 1990 Nov; 19(10):486-9. PubMed ID: 2286929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized double-blind, placebo-controlled trial evaluating oral glutamine on radiation-induced oral mucositis and dermatitis in head and neck cancer patients.
    Huang CJ; Huang MY; Fang PT; Chen F; Wang YT; Chen CH; Yuan SS; Huang CM; Luo KH; Chuang HY; Wang YY; Lee HH
    Am J Clin Nutr; 2019 Mar; 109(3):606-614. PubMed ID: 30753262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of selective elimination of the oral flora on mucositis in irradiated head and neck cancer patients.
    Spijkervet FK; Van Saene HK; Van Saene JJ; Panders AK; Vermey A; Mehta DM; Fidler V
    J Surg Oncol; 1991 Mar; 46(3):167-73. PubMed ID: 2011028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactobacillus brevis CD2 lozenges reduce radiation- and chemotherapy-induced mucositis in patients with head and neck cancer: a randomized double-blind placebo-controlled study.
    Sharma A; Rath GK; Chaudhary SP; Thakar A; Mohanti BK; Bahadur S
    Eur J Cancer; 2012 Apr; 48(6):875-81. PubMed ID: 21741230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylaxis of radiation-associated mucositis in conventionally treated patients with head and neck cancer: a double-blind, phase III, randomized, controlled trial evaluating the clinical efficacy of an antimicrobial lozenge using a validated mucositis scoring system.
    El-Sayed S; Nabid A; Shelley W; Hay J; Balogh J; Gelinas M; MacKenzie R; Read N; Berthelet E; Lau H; Epstein J; Delvecchio P; Ganguly PK; Wong F; Burns P; Tu D; Pater J
    J Clin Oncol; 2002 Oct; 20(19):3956-63. PubMed ID: 12351592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blinded, placebo-controlled trial on intravenous L-alanyl-L-glutamine in the incidence of oral mucositis following chemoradiotherapy in patients with head-and-neck cancer.
    Cerchietti LC; Navigante AH; Lutteral MA; Castro MA; Kirchuk R; Bonomi M; Cabalar ME; Roth B; Negretti G; Sheinker B; Uchima P
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1330-7. PubMed ID: 16765532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human epidermal growth factor treatment of radiation-induced severe oral mucositis in patients with head and neck malignancies.
    Hong JP; Lee SW; Song SY; Ahn SD; Shin SS; Choi EK; Kim JH
    Eur J Cancer Care (Engl); 2009 Nov; 18(6):636-41. PubMed ID: 19456848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial.
    Bentzen SM; Saunders MI; Dische S; Bond SJ
    Radiother Oncol; 2001 Aug; 60(2):123-35. PubMed ID: 11439207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of benzydamine oral rinse in prevention and management of radiation-induced oral mucositis: A double-blind placebo-controlled randomized clinical trial.
    Sheibani KM; Mafi AR; Moghaddam S; Taslimi F; Amiran A; Ameri A
    Asia Pac J Clin Oncol; 2015 Mar; 11(1):22-7. PubMed ID: 25471468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation mucositis: a new approach to prevention and treatment.
    McIlroy P
    Eur J Cancer Care (Engl); 1996 Sep; 5(3):153-8. PubMed ID: 9117049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of chlorhexidine rinsing on the oropharyngeal ecology in patients with head and neck cancer who have irradiation mucositis.
    Spijkervet FK; van Saene HK; Panders AK; Vermey A; van Saene JJ; Mehta DM; Fidler V
    Oral Surg Oral Med Oral Pathol; 1989 Feb; 67(2):154-61. PubMed ID: 2919059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901.
    Ryu JK; Swann S; LeVeque F; Scarantino CW; Johnson D; Chen A; Fortin A; Pollock J; Kim H; Ang KK
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):643-50. PubMed ID: 17293228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chlorhexidine prophylaxis for chemotherapy- and radiotherapy-induced stomatitis: a randomized double-blind trial.
    Ferretti GA; Raybould TP; Brown AT; Macdonald JS; Greenwood M; Maruyama Y; Geil J; Lillich TT; Ash RC
    Oral Surg Oral Med Oral Pathol; 1990 Mar; 69(3):331-8. PubMed ID: 2179802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized double-blind, placebo-controlled trial of zinc sulfate supplementation for alleviation of radiation-induced oral mucositis and pharyngitis in head and neck cancer patients.
    Sangthawan D; Phungrassami T; Sinkitjarurnchai W
    J Med Assoc Thai; 2013 Jan; 96(1):69-76. PubMed ID: 23720981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylaxis with povidone-iodine against induction of oral mucositis by radiochemotherapy.
    Adamietz IA; Rahn R; Böttcher HD; Schäfer V; Reimer K; Fleischer W
    Support Care Cancer; 1998 Jul; 6(4):373-7. PubMed ID: 9695205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentoxifylline and vitamin E reduce the severity of radiotherapy-induced oral mucositis and dysphagia in head and neck cancer patients: a randomized, controlled study.
    Sayed R; El Wakeel L; Saad AS; Kelany M; El-Hamamsy M
    Med Oncol; 2019 Nov; 37(1):8. PubMed ID: 31748905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sucralfate in the prevention of radiation-induced oral mucositis.
    Cengiz M; Ozyar E; Oztürk D; Akyol F; Atahan IL; Hayran M
    J Clin Gastroenterol; 1999 Jan; 28(1):40-3. PubMed ID: 9916664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized double-blind placebo-controlled trial of celecoxib for oral mucositis in patients receiving radiation therapy for head and neck cancer.
    Lalla RV; Choquette LE; Curley KF; Dowsett RJ; Feinn RS; Hegde UP; Pilbeam CC; Salner AL; Sonis ST; Peterson DE
    Oral Oncol; 2014 Nov; 50(11):1098-103. PubMed ID: 25151488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.